Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,2,1.07 [1.03-1.11],0.000373102670939968,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter IX Diseases of the circulatory system,I9_HYPTENSPOR,Wald ratio,1,1.06 [1.02-1.09],0.00082038726931379,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,8,1.07 [1.02-1.13],0.0123912146648471,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,2,1.04 [1.01-1.07],0.0189057339539717,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,2,1.05 [1.01-1.09],0.0208816143417082,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Inverse variance weighted,3,1.04 [1-1.08],0.0447225317280927,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Wald ratio,1,0.94 [0.88-1.01],0.0828290020560248,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter II Neoplasms,CD2_LYMPHOID_LEUKAEMIA_EXALLC,Inverse variance weighted,8,0.97 [0.93-1.01],0.160693714347453,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Wald ratio,1,1.02 [0.99-1.06],0.169104743684593,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Wald ratio,1,0.88 [0.71-1.08],0.218437145250674,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter II Neoplasms,C3_CLL_EXALLC,Inverse variance weighted,4,0.98 [0.94-1.01],0.222458754546836,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,69,1.02 [0.99-1.04],0.254935935672016,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Wald ratio,1,0.85 [0.62-1.16],0.307242659481228,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Wald ratio,1,1.06 [0.94-1.19],0.330072894343852,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Wald ratio,1,1.08 [0.93-1.25],0.332310606704906,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter X Diseases of the respiratory system,J10_LOWERINF,Wald ratio,1,1.12 [0.88-1.43],0.343303659186584,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Wald ratio,1,0.88 [0.65-1.19],0.412172093811525,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,2,1.08 [0.89-1.31],0.436986070720085,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,4,0.96 [0.87-1.07],0.503993914851831,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Wald ratio,1,1.06 [0.85-1.33],0.57890839034828,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Wald ratio,1,1.02 [0.95-1.1],0.635558665317512,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Wald ratio,1,1.03 [0.86-1.24],0.708841941395301,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,3,0.97 [0.78-1.19],0.744173312047473,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Wald ratio,1,0.95 [0.69-1.3],0.754863631525537,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,7,1.01 [0.93-1.1],0.782416044262204,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,4,0.98 [0.82-1.17],0.801323590278438,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Wald ratio,1,1.03 [0.8-1.32],0.830068098336776,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter X Diseases of the respiratory system,ILD,Inverse variance weighted,21,1 [0.98-1.02],0.879907752373031,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Wald ratio,1,0.99 [0.79-1.25],0.934649472397704,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,3,1 [0.96-1.04],0.961230360673566,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter X Diseases of the respiratory system,J10_INTERSTITIUM,Inverse variance weighted,4,1 [0.97-1.03],0.963339151479787,trans
GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Chapter V Mental and behavioural disorders,AUD,Inverse variance weighted,6,1 [0.94-1.06],0.99796036157804,trans
